Extramedullary Involvement at Relapse in Acute Promyelocytic Leukemia Patients Treated or Not With All-<i>Trans</i> Retinoic Acid: A Report by the Gruppo Italiano Malattie Ematologiche dell’Adulto

2001135 citationsJournal Article

Authors

Giorgina Specchia · Istituto di Ematologia di Bologna

Francesco Lo‐Coco · Istituto di Ematologia di Bologna

Marco Vignetti · Istituto di Ematologia di Bologna

Giuseppe Avvisati · Istituto di Ematologia di Bologna

Paola Fazi · Istituto di Ematologia di Bologna

Francesco Albano · Istituto di Ematologia di Bologna

Francesco Di Raimondo

Abstract

APL patients receiving all-trans retinoic acid in addition to chemotherapy have no increased risk of developing EMD at relapse as compared with those treated with chemotherapy alone.

Topics & Keywords

Retinoids in leukemia and cellular processes Acute Myeloid Leukemia Research Acute Lymphoblastic Leukemia research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 19, Issue 20, pp. 4023-4028

DOI: 10.1200/jco.2001.19.20.4023

Field-Weighted Citation Impact: 2.78